Wind数据显示，截至9月30日，今年以来上证指数、深证成指、创业板指分别累计上涨15.84%、29.88%、 51.20%。 市场持续走强，低价股数量也随之减少。截至9月30日，最新收盘价（前复权）在2元以下的低价股数量仅剩31 只。 2元以下低价股数量为31只 Wind数据显示，截至9月30日，收盘价（前复权）低于2元的低价股数量为31只。其中股价最低的是*ST高鸿，最 新收盘价为0.38元。 31只低价股中，除紫天退为创业板股票外，其他均为主板股票。按照申万一级行业划分，房地产行业低价股数量 最多，有7只，建筑装饰行业有4只，钢铁行业有3只，医药生物、基础化工、交通运输行业均为2只。 从市值规模看，在31只低价股中，市值低于100亿元的股票有19只，占比超六成；业绩表现方面，有21只低价股 2025年上半年归母净利润为亏损状态，整体业绩表现不佳；从股价表现来看，有22只低价股今年以来股价下跌， 占比超七成。 Wind数据显示，截至9月30日，今年以来，剔除上市新股，A股共有4356只股票涨幅为正，占比超八成。其中， 1361只股票涨幅在50%以上，446只股票涨超100%。 在446只涨幅超100%的股 ...

31只低价股中，除紫天退为创业板股票外，其他均为主板股票。按照申万一级行业划分，房地产行业低价股数量 最多，有7只，建筑装饰行业有4只，钢铁行业有3只，医药生物、基础化工、交通运输行业均为2只。 从市值规模看，在31只低价股中，市值低于100亿元的股票有19只，占比超六成；业绩表现方面，有21只低价股 2025年上半年归母净利润为亏损状态，整体业绩表现不佳；从股价表现来看，有22只低价股今年以来股价下跌， 占比超七成。 最新收盘价（前复权）在2元以下的个股 | 证券代码 | 证券简称 | 今年以来涨 | 最新收盘价 | 最新总市值 | 所属申万 | | --- | --- | --- | --- | --- | --- | | | | 幅(%) | (元) | (亿元) | 级行业 | | 000851. SZ | *ST高湾 | -87. 42 | 0. 38 | 4. 40 | 通信 | | 300280. SZ | 紫天退 | -98. 20 | 0. 38 | 0. 62 | 传媒 | | 600200. SH | *ST苏吴 | -89. 81 | 0. 95 | 6. 75 | 医药生物 | | ...

Core Viewpoint - A number of companies have announced shareholder reduction plans following significant stock price increases, particularly among popular concept stocks, indicating a potential shift in market sentiment and investor behavior [1][4]. Group 1: Shareholder Reduction Plans - On May 13, over ten companies, including Gaozheng Mingbao, Haichuang Pharmaceutical, and Cambridge Technology, disclosed shareholder reduction plans, with many shareholders planning to reduce their stakes by over 2% [1][2]. - Cambridge Technology's shareholders plan to reduce a total of 804.12 million shares and 186.27 million shares, representing 3% of the company's shares, with a total reduction amounting to approximately 3.95 billion yuan based on the latest closing price [2]. - Other companies like Gaozheng Mingbao and New Strong Link also reported significant planned reductions, with amounts exceeding 2 billion yuan [2][3]. Group 2: Stock Performance - Since April 8, the Shanghai and Shenzhen markets have experienced a significant rally, with the Shanghai Composite Index rebounding by 9.93% and the Shenzhen Component Index rising by 15.27% [4]. - Companies like Haichuang Pharmaceutical, Cambridge Technology, and Gaozheng Mingbao have seen stock price increases of over 19% in May, reaching new highs for the year [4][5]. - Despite substantial stock price increases, some companies, such as Haichuang Pharmaceutical, continue to report poor financial performance, with ongoing losses and no revenue generation [5][6]. Group 3: Historical Context of Reductions - Several companies have experienced multiple rounds of shareholder reductions prior to the recent announcements, indicating a trend of ongoing divestment by major shareholders [6]. - For instance, Haichuang Pharmaceutical's second-largest shareholder recently completed a reduction of 334.42 million shares, while Cambridge Technology has faced frequent reductions from its shareholders since last year [6][7]. - If the current reduction plans are fully executed, some shareholders will fall below the 5% threshold, eliminating the need for future disclosure of further reductions [7].